PROXEN NP 660
NDC 69729-123, Naproxen Sodium, tablet, from OPMX LLC.
- Product NDC
- 69729-123
- Status
- Listed
- Labeler
- OPMX LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA091353
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69729-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69729-123-12 | 69729012312 | 1 BLISTER PACK in 1 CARTON (69729-123-12) / 12 TABLET in 1 BLISTER PACK |
| 69729-123-24 | 69729012324 | 2 BLISTER PACK in 1 CARTON (69729-123-24) / 12 TABLET in 1 BLISTER PACK |
| 69729-123-50 | 69729012350 | 50 POUCH in 1 CARTON (69729-123-50) / 2 TABLET in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69729-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69729-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69729-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.